Progress on Chitosan Nanoparticles as Drug Delivery Carriers

Zhi Hua Xing

doi:10.4028/www.scientific.net/AMR.684.53

Paper Titles

New Two-Step Preparation and Characterization of Submicron ZnO Rods Arrays
p.32

The Study on Deposition Process and Mechanical Properties of Deposited Cu Thin Films Using Molecular Dynamics
p.37

Progress on Cytotoxicity In Vitro of Carbon Nanotubes
p.42

Synthesis of Nanosized Pseudoboehmite and γ-Al₂O₃ by Control Precipitation Method
p.46

Progress on Chitosan Nanoparticles as Drug Delivery Carriers
p.53

Preparation and Characterization of Folate-Decorated Chitosan Microspheres as a Sustained-Release Drugs Carrier
p.57

Effect of Thermal Treatment on the Texture and Structure of Sol-Gel Derived Carbon Nanotube/Silica Composites
p.63

Effect of SiO₂ Particle Size on Optical Properties of TiO₂-SiO₂ Nanocomposite Thin Films
p.67

Processing, Thermal Behavior and Tensile Properties of PLA/Thermoplastic Starch/Montmorillonite Nanocomposites
p.75

HomeAdvanced Materials ResearchAdvanced Materials Research Vol. 684Progress on Chitosan Nanoparticles as Drug...

Progress on Chitosan Nanoparticles as Drug Delivery Carriers

Abstract:

To review the progress on chitosan nanoparticles as drug delivery carriers, the application of chitosan nanoparticles in the fields of organ targeting, DNA transfection, and non-injection administration are summarized according to recent references. The results showed that chitosan nanoparticles as a new drug carrier have important value of research and extensively development prospect.

You might also be interested in these eBooks

Advances in Applied Materials and Electronics Engineering II

View Preview

Info:

Periodical:

Advanced Materials Research (Volume 684)

Pages:

53-56

DOI:

https://doi.org/10.4028/www.scientific.net/AMR.684.53

Citation:

Cite this paper

Online since:

April 2013

Authors:

Zhi Hua Xing

Keywords:

Biological Uptake, Chitosan Nanoparticles, Cytotoxicity, New Drug Delivery

Export:

RIS, BibTeX

Price:

Permissions CCC:

Request Permissions

Permissions PLS:

Request Permissions

Сopyright:

Citation:

References

[1] Huang M, Ma Z, Khor E. Uptake of FITC-chitosan nanoparticles by A 549 cells [J]. Pharm res. 2002, 19(10): 1488-1494.

Google Scholar

[2] Huang M, Ma Z, Khor E, Lim LY, et al. Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation[J]. Pharm res. 2004, 21(2): 344-353.

DOI: 10.1023/b:pham.0000016249.52831.a5

Google Scholar

[3] Ma Z, Lim LY, et al. Uptake of chitosan and associated insulin in caco-2 cell monolayers: a comparison between chitosan molecules and chitosan nanoparticles : effects of molecular weight and degree of deacetylation[J]. Pharm res. 2003, 20(11): 1812-1819.

DOI: 10.1023/b:pham.0000003379.76417.3e

Google Scholar

[4] Janes KA, Fresneau MP, Marazuela A, et al. chitosan nanoparticles as delivery systems for doxorubicin[J]. J Control Release. 2001, 73（2-3）：255-267.

DOI: 10.1016/s0168-3659(01)00294-2

Google Scholar

[5] Mitra S, Gaur U, Chosh PC, et al. Tumour targeted delivery of eucapsulated dextran- doxorubicin conjugate using chitosan nanoparticles as carrier[J]. J Control Release 2001, 74（1-3）：317-323.

DOI: 10.1016/s0168-3659(01)00342-x

Google Scholar

[6] Mao HQ, Roy K, Troung-Le VL, et al. chitosan DNA nanoparticles as gene delivery carriers: Synthesis characterization and transfection efficiency [J]. J Control Release 2001, 70 （3）：399-421.

DOI: 10.1016/s0168-3659(00)00361-8

Google Scholar

[7] Park IK, Jiang HL, Cook SE, et al. Galactosylated chitosan (GC)-graft-poly(vinyl pyrrolidone)(pvp) as hepatocyle-targeting DNA carrier in vitro transfection, MG63 and HEK293 transfection [J]. Arch Pharm res. 2004, 27(12): 1284-1289.

DOI: 10.1007/bf02975895

Google Scholar

[8] Kim TH, Kim SL, Akaike T, et al. Synergistic effect of poly(ethylenimine)on the transfection efficiency of galactosylated chitosan / DNA complexes [J]. J Control Release 2005, 105（3）: 354-366.

DOI: 10.1016/j.jconrel.2005.03.024

Google Scholar

[9] Vila A, Sanchez A, Janes K, et al. low molecular weight chitosan nanoparticles as new carriaers for nasal vaccine delivery in mice [J]. Eur J Pharm Biopharm. 2004, 57(1): 123-131.

DOI: 10.1016/j.ejpb.2003.09.006

Google Scholar

[10] Decampos AM, Sancheiz A, Alonso MJ. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A[J]. Int J Pharm, 2001, 224（1-2）：159-168.

DOI: 10.1016/s0378-5173(01)00760-8

Google Scholar

[11] Decampos AM, Diebold Y, Carvalho EL, et al. Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity[J]. Pharm Res. 2004, 21 （5）: 803-810.

DOI: 10.1023/b:pham.0000026432.75781.cb

Google Scholar